Indications
Open Access TIMES Journals
Login
Register
Login
Register
Indications
Oncology · Hematology
Cardiovascular
Diabetes + Endocrinology
Pneumology
Ophthalmology
Gynecology · Urology
Dermatology · Immunology · Rheumatology
Neurology · Psychiatry
Gastroenterology
Infectiology · Anesthesiology · Pain
Primary Care
Open Access TIMES Journals
Oncology · Hematology
Cardiovascular
Diabetes + Endocrinology
Pneumology
Ophthalmology
Gynecology · Urology
Dermatology · Immunology · Rheumatology
Neurology · Psychiatry
Gastroenterology
Infectiology · Anesthesiology · Pain
Primary Care
Gynecology · Urology
Case Reports
Expert Opinions
Webinar
Faculty
Homepage
>
Gynecology · Urology
>
Articles
Associations among statins, preventive care, and prostate cancer mortality
Uro-Oncology
Share:
Related content
Uro-Oncology
Red and processed meat, poultry, fish and egg intakes and cause-specific and all-cause mortality among men with non-metastatic prostate cancer in a US Cohort
Cancer Epidemiol Biomarkers Prev.
Wang Y, Jacobs EJ, Shah RA, Stevens VL, Gansler T, McCullough ML
doi: 10.1158/1055-9965.EPI-19-1426.
Uro-Oncology
Association of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or Radiotherapy: A Systematic Review and Meta-analysis
JAMA Oncol.
Foerster B, Pozo C, Abufaraj M, Mari A, Kimura S, D'Andrea D, John H, Shariat SF
doi: 10.1001/
Uro-Oncology
Prostate cancer-specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial priorities
Prostate.
Dee EC, Nezolosky MD, Chipidza FE, Arega MA, Butler SS, Sha ST, Mahal BA, Nguyen PL, Yang DD, Muralidhar V
doi: 10.1002/pros.24041.
Uro-Oncology
The deleterious association between proton pump inhibitors and prostate cancer-specific mortality - a population-based cohort study
Prostate Cancer Prostatic Dis.
Goldberg H, Mohsin FK, Saskin R, Kulkarni GS, Berlin A, Kenk M, Wallis CJD, Chandrasekar T, Klaassen Z, Saarela O, Penn L, Alibhai SMH, Fleshner N
doi: 10.1038/s41391-020-0248-9.
Uro-Oncology
Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies
Prostate Cancer Prostatic Dis.
Mazzone E, Mistretta FA, Knipper S, Tian Z, Palumbo C, Gandaglia G, Fossati N, Shariat SF, Saad F, Montorsi F, Graefen M, Briganti A, Karakiewicz PI
doi: 10.1038/s41391-019-0183-9.
Uro-Oncology
Further Publications Urology
Improved survival with post-diagnostic metformin and statin use in a racially diverse cohort of US Veterans with advanced prostate cancer
Prostate Cancer Prostatic Dis
Khan S, Chang SH, Hicks V, Wang M, Grubb RL 3rd, Drake BF
doi: 10.1038/s41391-021-00475-5
Uro-Oncology
The association between occupational asbestos exposure with the risk of incidence and mortality from prostate cancer: a systematic review and meta-analysis
Prostate Cancer Prostatic Dis
Godono A, Clari M, Franco N, Ciocan C, Mansour I, Zunarelli C, Pira E, Boffetta P
doi: 10.1038/s41391-021-00437-x
Uro-Oncology
Association between metformin medication, genetic variation and prostate cancer risk
Prostate Cancer Prostatic Dis.
Lee MJ, Jayalath VH, Xu W, Lu L, Freedland SJ, Fleshner NE, Kulkarni GS, Finelli A, van der Kwast TH, Hamilton RJ
doi: 10.1038/s41391-020-0238-y.
Uro-Oncology
The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial
Prostate.
Chadid S, Barber JR, Nelson WG, Gurel B, Lucia MS, Thompson IM, Goodman PJ, Stanczyk FZ, Parnes HL, Lippman SM, De Marzo AM, Platz EA
doi: 10.1002/pros.24023.
